These asthmatic features present as repeated periods of wheezing, shortness of breath, coughing, and tightness of the chest [1]
We previously compared the c-Fos activation pattern in NTS preproglucagon (PPG) neurons following liraglutide administration with that induced by food restriction
The first head-to-head clinical trial (SURMOUNT-5, published in the New England Journal of Medicine in 2025) showed tirzepatide produced 20.2% average weight loss at 72 weeks compared to 13.7% for semaglutide approximately 47% greater relative weight loss
Expect similar programs for retatrutide if approved
Judicial Panel on Multidistrict Litigation will hear arguments on Eli Lilly's petition to consolidate vision loss lawsuits
Each technology offers potential benefits like improved bioavailability or better absorption sites, but also faces challenges such as manufacturing difficulties, high costs, and regulatory hurdles